These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15017268)

  • 1. Sensitivity of renal cell carcinoma to aminoflavone: role of CYP1A1.
    Loaiza-Pérez AI; Kenney S; Boswell J; Hollingshead M; Hose C; Linehan WM; Worrell R; Rubinstein L; Sausville EA; Vistica DT
    J Urol; 2004 Apr; 171(4):1688-97. PubMed ID: 15017268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aryl hydrocarbon receptor activation by aminoflavone: new molecular target for renal cancer treatment.
    Callero MA; Suárez GV; Luzzani G; Itkin B; Nguyen B; Loaiza-Perez AI
    Int J Oncol; 2012 Jul; 41(1):125-34. PubMed ID: 22485252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models.
    Kadhim SA; Bowlin TL; Waud WR; Angers EG; Bibeau L; DeMuys JM; Bednarski K; Cimpoia A; Attardo G
    Cancer Res; 1997 Nov; 57(21):4803-10. PubMed ID: 9354442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effects of an imidazoquinoline in renal cell carcinoma.
    Schwartz MJ; Liu H; Hwang DH; Kawamoto H; Scherr DS
    Urology; 2009 May; 73(5):1156-62. PubMed ID: 19118885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix.
    Inamoto T; Yamochi T; Ohnuma K; Iwata S; Kina S; Inamoto S; Tachibana M; Katsuoka Y; Dang NH; Morimoto C
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3470-7. PubMed ID: 16740772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of apoptosis in human renal cell carcinoma cells by vitamin E succinate in caspase-independent manner.
    Wu XX; Kakehi Y; Jin XH; Inui M; Sugimoto M
    Urology; 2009 Jan; 73(1):193-9. PubMed ID: 18692875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.
    Köpf-Maier P
    Anticancer Res; 1999; 19(1A):493-504. PubMed ID: 10226588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topotecan (Hycamtin) responsiveness in human renal carcinoma cell lines of the clear cell and papillary types.
    Ramp U; Mahotka C; Kalinski T; Ebel E; Gabbert HE; Gerharz CD
    Anticancer Res; 2001; 21(5):3509-17. PubMed ID: 11848517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapy of experimental renal cell carcinoma with a novel conjugate of monoclonal antibody 138H11 and calicheamicin thetaI1.
    Knoll K; Wrasidlo W; Scherberich JE; Gaedicke G; Fischer P
    Cancer Res; 2000 Nov; 60(21):6089-94. PubMed ID: 11085532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for and identification of novel agents directed at renal cell carcinoma.
    Mertins SD; Myers TG; Hollingshead M; Dykes D; Bodde E; Tsai P; Jefferis CA; Gupta R; Linehan WM; Alley M; Bates SE
    Clin Cancer Res; 2001 Mar; 7(3):620-33. PubMed ID: 11297258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Ki-67 in a renal cell carcinoma severe combined immunodeficiency disease mouse model is associated with induction of apoptosis and tumour growth inhibition.
    Kausch I; Jiang H; Ewerdwalbesloh N; Doehn C; Krüger S; Sczakiel G; Jocham D
    BJU Int; 2005 Feb; 95(3):416-20. PubMed ID: 15679806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of human natural interferon-alpha and mismatched double-stranded RNA against a human renal cell carcinoma xenograft.
    Hubbell HR; Pequignot EC; Shanabrook KR; Carter WA; Williams RD; Strayer DR
    Anticancer Res; 1990; 10(3):795-801. PubMed ID: 2369093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative and antitumor effects of alpha-interferon in renal cell carcinomas: correlation with the expression of a kidney-associated differentiation glycoprotein.
    Nanus DM; Pfeffer LM; Bander NH; Bahri S; Albino AP
    Cancer Res; 1990 Jul; 50(14):4190-4. PubMed ID: 2364374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alkylator treosulfan shows activity towards human renal-cell carcinoma in vivo and in vitro.
    Köpf-Maier P
    In Vivo; 1998; 12(3):275-88. PubMed ID: 9706471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro chemotherapy sensitivity testing for human kidney tumor lines: a comparative study.
    Kurth KH; Romijn JC; Kappendijk M; Weissglas MG; van Dongen JW
    Semin Surg Oncol; 1988; 4(2):103-9. PubMed ID: 3393774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma.
    Kato Y; Yoshimura K; Shin T; Verheul H; Hammers H; Sanni TB; Salumbides BC; Van Erp K; Schulick R; Pili R
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4538-46. PubMed ID: 17671140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verotoxin induces rapid elimination of human renal tumor xenografts in SCID mice.
    Ishitoya S; Kurazono H; Nishiyama H; Nakamura E; Kamoto T; Habuchi T; Terai A; Ogawa O; Yamamoto S
    J Urol; 2004 Mar; 171(3):1309-13. PubMed ID: 14767339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GTI-2040 displays cooperative anti-tumor activity when combined with interferon alpha against human renal carcinoma xenografts.
    Vassilakos A; Lee Y; Viau S; Feng N; Jin H; Chai V; Wang M; Avolio T; Wright J; Young A
    Int J Oncol; 2009 Jan; 34(1):33-42. PubMed ID: 19082475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zoledronic acid induces caspase-dependent apoptosis in renal cancer cell lines.
    Ullen A; Schwarz S; Lennartsson L; Kalkner KM; Sandstrom P; Costa F; Lennernas B; Linder S; Nilsson S
    Scand J Urol Nephrol; 2009; 43(2):98-103. PubMed ID: 19101859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligands for peroxisome proliferator-activated receptor gamma have potent antitumor effect against human renal cell carcinoma.
    Yuan J; Takahashi A; Masumori N; Uchida K; Hisasue S; Kitamura H; Itoh N; Tsukamoto T
    Urology; 2005 Mar; 65(3):594-9. PubMed ID: 15780399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.